科恩-斯蒂爾斯金融 CNS 深滬

等待開盤 11-26 09:30:00 美东时间

62.76

+0.800

+1.29%

華盛通

立即下載

最高63.39
今開62.19
成交量 49.63万股
最低 62.19
昨收 61.96
總市值 32.01亿
52周最高 99.69
市盈率 ^靜 21.13
換手率 0.00%
52周最低 58.80
委比 0.00%
總股本 5099.67万
歷史最高 107.60
量比 0.68
振幅 1.94%
歷史最低 -5.51
每手 1
風險率 9.10%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Cohen & Steers Announces Changes to Realty Indexes

NEW YORK, Nov. 14, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Por...

11-15 05:05
Cohen & Steers, Inc. Declares Quarterly Dividend

NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the fourth quarter of 2025 in the amount of $0.62 per share of...

10-31 04:22
Alpha Buying: When Insiders Buy Big & Why It Works in Every Market

Every market cycle has its own cast of optimists and skeptics. But few voices c...

10-30 22:57
Supernus a new buy at BofA on 'underappreciated' CNS assets

BofA Securities has initiated coverage of Supernus Pharmaceuticals (SUPN) at buy saying that the market is not fully appreciating the company's portfolio of central nervous system drugs. The bank set ...

10-30 02:37
Uncovering Potential: Alnylam Pharmaceuticals's Earnings Preview

Alnylam Pharmaceuticals (NASDAQ:ALNY) is gearing up to announce its quarterly e...

10-29 22:04
Rakovina Therapeutics Unveils AI-Developed ATR Inhibitors with CNS Penetration

The latest update is out from Rakovina Therapeutics Inc ( ($TSE:RKV) ). Rakovin...

10-27 16:32
Biogen's Immunology Pipeline Has Long-Term Potential: Analyst

Biogen gains exclusive rights to Vanqua's oral C5aR1 antagonist, boosting its immunology pipeline with potential across multiple immune diseases.

10-25 00:47
Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce

Alector's Phase 3 trial for FTD-GRN drug, latozinemab, failed the clinical co-primary endpoint. The program is discontinued; Alector cuts 49% of staff.

10-23 00:07
Plus Therapeutics Expands CNSide Diagnostic Business, Lands National Coverage Deal With UnitedHealthcare

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers,

10-21 19:42
美股大行评级 | 潜在涨幅344.44%！Rani Therapeutics获Maxim Group升目标价至10美元，维持"买入"评级

今日重点评级关注：Maxim Group：维持Rani Therapeutics Hldgs"买入"评级，目标价从5美元升至10美元；韦德布什：维持Corbus Pharmaceuticals"跑赢大市"评级，目标价从31美元升至38美元

10-21 18:13

派息除權日	每股總股息	派息日期
2025-11-10	0.62	2025-11-20
2025-08-11	0.62	2025-08-21
2025-05-12	0.62	2025-05-22
2025-03-03	0.62	2025-03-13
2024-11-18	0.59	2024-12-02
2024-08-12	0.59	2024-08-22
2024-05-10	0.59	2024-05-23
2024-03-01	0.59	2024-03-14
2023-11-10	0.57	2023-11-28
2023-08-11	0.57	2023-08-24
2023-05-12	0.57	2023-05-25
2023-03-03	0.57	2023-03-16
2022-11-10	0.55	2022-11-29
2022-08-12	0.55	2022-08-25
2022-05-13	0.55	2022-05-26
2022-03-04	0.55	2022-03-17
2021-11-12	1.70	2021-11-30
2021-08-13	0.45	2021-08-26
2021-05-14	0.45	2021-05-27
2021-03-05	0.45	2021-03-18
2020-11-13	1.39	2020-12-01
2020-08-14	0.39	2020-08-27
2020-05-15	0.39	2020-06-02
2020-02-28	0.39	2020-03-12
2019-11-15	2.36	2019-12-03
2019-08-09	0.36	2019-08-22
2019-05-10	0.36	2019-05-23
2019-03-01	0.36	2019-03-14
2018-11-16	2.83	2018-12-03
2018-08-15	0.33	2018-08-30
2018-05-30	0.33	2018-06-21
2018-03-07	0.33	2018-03-22
2017-11-21	1.28	2017-12-13
2017-08-30	0.28	2017-09-21
2017-05-30	0.28	2017-06-22
2017-03-07	0.28	2017-03-23
2016-11-21	0.76	2016-12-14
2016-08-30	0.26	2016-09-22
2016-05-31	0.26	2016-06-23
2016-03-07	0.26	2016-03-23
2015-11-23	0.75	2015-12-16
2015-09-01	0.25	2015-09-24
2015-05-29	0.25	2015-06-25
2015-03-11	0.25	2015-03-26
2014-11-25	1.22	2014-12-19
2014-09-03	0.22	2014-09-26
2014-05-30	0.22	2014-06-26
2014-03-26	0.22	2014-04-11
2013-11-27	1.20	2013-12-20
2013-09-04	0.20	2013-09-27
2013-05-30	0.20	2013-06-26
2013-03-25	0.20	2013-04-12
2012-11-28	1.68	2012-12-20
2012-09-05	0.18	2012-09-27
2012-05-31	0.18	2012-06-28
2012-03-27	0.18	2012-04-13
2011-12-05	0.15	2011-12-28
2011-09-02	1.15	2011-09-28
2011-06-01	0.15	2011-06-28
2011-03-29	0.15	2011-04-15
2010-12-02	0.10	2010-12-29
2010-09-02	2.10	2010-09-27
2010-06-02	0.10	2010-06-28
2010-03-29	0.10	2010-04-16
2009-12-02	0.05	2009-12-29
2009-09-02	0.05	2009-09-25
2009-06-02	0.05	2009-06-26
2009-03-27	0.05	2009-04-17
2008-12-03	0.10	2008-12-29
2008-09-03	0.22	2008-09-27
2008-06-02	0.22	2008-06-27
2008-03-07	0.22	2008-03-28
2007-12-03	0.20	2007-12-27
2007-08-31	0.20	2007-09-27
2007-05-31	0.20	2007-06-27
2007-03-30	0.20	2007-04-24
2006-12-28	0.13	2007-01-23
2006-09-28	0.13	2006-10-23
2006-06-27	0.11	2006-07-19
2006-03-27	0.11	2006-04-19
2005-12-27	0.11	2006-01-18
2005-09-27	0.11	2005-10-18
2005-06-27	0.10	2005-07-18
2005-03-24	0.10	2005-04-15
2004-12-27	0.10	2005-01-17
2004-09-23	0.10	2004-10-11

公司名稱	科恩-斯蒂尔斯金融
行業分類	资产管理
業務描述	Cohen & Steers, Inc. is a holding company, which operates as an investment manager specializing in liquid real assets, which include real estate securities, listed infrastructure, commodities, natural resource equities, preferred securities, and other income solutions. It manages investment vehicles, such as institutional accounts, open-end funds and closed-end funds. The company was founded by Martin Cohen and Robert Hamilton Steers in 1986 and is headquartered in New York, NY.

科恩-斯蒂爾斯金融 CNS 深 滬

62.76

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

科恩-斯蒂爾斯金融 CNS 深滬